DRIO (DarioHealth) Other Current Payables: $5.01 Mil (As of Mar. 2026)


DRIO DarioHealth Corp DRIO
58 GF Score
Price $7.22
GF Value $7.06
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Other Current Payables?

DarioHealth DRIO +1.69% 58 Other Current Payables is $5.01 Mil as of Mar. 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.06 (Fairly Valued). The stock has 4 warning signs investors should review.

DarioHealth's Other Current Payables for the quarter that ended in Mar. 2026 was $5.01 Mil.

DarioHealth's quarterly Other Current Payables declined from Sep. 2025 ($4.51 Mil) to Dec. 2025 ($0.00 Mil) but then increased from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($5.01 Mil).

DarioHealth Other Current Payables Related Terms

DarioHealth Other Current Payables Historical Data

* Premium members only.

The historical data trend for DarioHealth's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth Other Current Payables Chart

DarioHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DarioHealth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 5.14 4.51 0.00 5.01
DRIO
58GF Score
DarioHealth Corp DRIO
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DarioHealth Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $5.01 Mil mean?
DarioHealth (DRIO) has a Other Current Payables of $5.01 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on DarioHealth and its competitors.
Is DarioHealth's Other Current Payables too high?
DarioHealth's current Other Current Payables is $5.01 Mil. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Other Current Payables compare to BEAT and ONMD?
DarioHealth's Other Current Payables of $5.01 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Healthcare Providers & Services company?
A good Other Current Payables depends on the Healthcare Providers & Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on DarioHealth and its competitors. DarioHealth's current Other Current Payables is $5.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.06, compared to a current price of $7.22 — trading 2.3% above its estimated fair value. The current Other Current Payables is $5.01 Mil. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For DarioHealth (DRIO), the current Other Current Payables is $5.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.22 is trading 2.3% above its estimated GF Value™ of $7.06. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • Other Current Payables: $5.01 Mil
  • GF Value™: $7.06 vs. price of $7.22 (2.3% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score

Get the complete analysis for DRIO

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.22
Price
$7.06
GF Value